|
ATAD2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.06569999953111E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.198860E-04 |
| Normal-vs-Stage2 |
1.864430E-03 |
| Normal-vs-Stage3 |
2.4904999999964E-05 |
| Normal-vs-Stage4 |
4.30670000000077E-05 |
| Stage1-vs-Stage2 |
6.715200E-01 |
| Stage1-vs-Stage3 |
9.574000E-02 |
| Stage1-vs-Stage4 |
9.164600E-03 |
| Stage2-vs-Stage3 |
4.297200E-01 |
| Stage2-vs-Stage4 |
2.749600E-02 |
| Stage3-vs-Stage4 |
7.131900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.11190000049189E-07 |
| Normal-vs-AfricanAmerican |
3.482000E-02 |
| Normal-vs-Asian |
1.553030E-01 |
| Caucasian-vs-AfricanAmerican |
1.779520E-02 |
| Caucasian-vs-Asian |
5.112800E-01 |
| AfricanAmerican-vs-Asian |
3.004600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.11079999987452E-07 |
| Normal-vs-Female |
2.420200E-04 |
| Male-vs-Female |
2.133600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.403730E-03 |
| Normal-vs-Age(41-60Yrs) |
2.29929999995271E-06 |
| Normal-vs-Age(61-80Yrs) |
1.70040999999399E-05 |
| Normal-vs-Age(81-100Yrs) |
1.523160E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.069400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.644600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.111370E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.425200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.291600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.901700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.532430E-02 |
| Normal-vs-Grade 2 |
7.59970000000498E-05 |
| Normal-vs-Grade 3 |
1.53832999999493E-05 |
| Normal-vs-Grade 4 |
7.84810000000746E-05 |
| Grade 1-vs-Grade 2 |
5.568200E-01 |
| Grade 1-vs-Grade 3 |
5.120200E-01 |
| Grade 1-vs-Grade 4 |
1.050110E-02 |
| Grade 2-vs-Grade 3 |
9.190800E-01 |
| Grade 2-vs-Grade 4 |
1.399850E-02 |
| Grade 3-vs-Grade 4 |
1.480140E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.795600E-04 |
| Normal-vs-ccB subtype |
1.58500000013717E-07 |
| ccA subtype-vs-ccB subtype |
5.078600E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.23979999997215E-06 |
| Normal-vs-N1 |
4.415200E-03 |
| N0-vs-N1 |
5.582200E-02 |
|
|
